⌕
Fortrea Holdings · FTRE · Nasdaq
Tenet 26 · Weak
Compare
$19.79−2.03%At closeTenet 26 · Weak
$19.79−0.41 (−2.03%)
At close: Nov 16, 2026, 4:00 PM ET· Nasdaq · USD

Fortrea Holdings (FTRE) News

What's actually happening: chronological and provenance-stamped. News is context, not a signal.

Sources News publishers NewsHow we compute thisNot investment advice

The percentage on each card is FTRE's move today, from the quote feed. It is the same figure on every headline, not the move on that headline's own date.

● Seeking AlphaNov 13, 2026 · 05:27 ET
Fortrea: A Promising Turnaround At An Attractive Valuation

Fortrea Holdings (FTRE) receives a buy rating due to operational restructuring, improving profitability, and a positive new orders trend despite ongoing revenue decline. FTRE's Q3 2026 results show adjusted EBITDA up 14.…

FTRE −2.0% todayRead at source ↗
● MarketBeatOct 29, 2026 · 13:02 ET
What Fortrea (FTRE) Said on Its Q3 Earnings Call

Fortrea NASDAQ: FTRE reported third-quarter 2026 revenue of $691.5 million, down 1.4% from a year earlier but up 2.0% sequentially, as the contract research organization cited improving demand, stronger operational execu…

FTRE −2.0% todayRead at source ↗
● Seeking AlphaOct 29, 2026 · 12:29 ET
Fortrea Holdings Inc. (FTRE) Q3 2026 Earnings Call Transcript

Fortrea Holdings Inc. (FTRE) Q3 2026 Earnings Call Transcript…

FTRE −2.0% todayRead at source ↗
● Zacks Investment ResearchOct 29, 2026 · 08:46 ET
Fortrea Holdings Inc. (FTRE) Q3 Earnings and Revenues Surpass Estimates

Fortrea Holdings Inc. (FTRE) came out with quarterly earnings of $0.28 per share, beating the Zacks Consensus Estimate of $0.24 per share. This compares to earnings of $0.12 per share a year ago.…

FTRE −2.0% todayRead at source ↗
● GlobeNewsWireOct 29, 2026 · 06:30 ETCOMPANY'S OWN WORDS
Fortrea Reports Third Quarter 2026 Results

Sustained commercial momentum, continued margin improvement, and targeted investments strengthen growth foundation Sustained commercial momentum, continued margin improvement, and targeted investments strengthen growth f…

FTRE −2.0% todayRead at source ↗
● GlobeNewsWireOct 27, 2026 · 07:00 ETCOMPANY'S OWN WORDS
Fortrea to Participate in Jefferies Global Healthcare Conference

DURHAM, N.C., Oct. 27, 2026 (GLOBE NEWSWIRE) -- Fortrea (Nasdaq: FTRE), a leading global contract research organization (“CRO”), today announced that CEO Anshul Thakral, CFO Jason Knoblauch, and SVP of Investor Relations…

FTRE −2.0% todayRead at source ↗
● GlobeNewsWireOct 22, 2026 · 16:05 ETCOMPANY'S OWN WORDS
Fortrea and Omico Collaboration to Advance Biomarker-led Oncology Drug Development

Collaboration aims to improve trial planning and expand patient access to biomarker-matched studies in Australia Collaboration aims to improve trial planning and expand patient access to biomarker-matched studies in Aust…

FTRE −2.0% todayRead at source ↗
● Zacks Investment ResearchOct 22, 2026 · 11:02 ET
Fortrea Holdings Inc. (FTRE) Earnings Expected to Grow: Should You Buy?

Fortrea Holdings Inc. (FTRE) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.…

FTRE −2.0% todayRead at source ↗
● GlobeNewsWireOct 19, 2026 · 16:05 ETCOMPANY'S OWN WORDS
Fortrea Completes Acquisition of the Early Phase Services Division from Worldwide Clinical Trials

Highlights Fortrea completes acquisition of the Early Phase Services division from Worldwide Clinical Trials Adds a 60,000-square-foot GLP-compliant bioanalytical laboratory in Austin, Texas; a 200-bed GCP-compliant clin…

FTRE −2.0% todayRead at source ↗
● Defense WorldOct 9, 2026 · 04:46 ET
MindWalk (NASDAQ:HYFT) & Fortrea (NASDAQ:FTRE) Head to Head Contrast

Fortrea (NASDAQ: FTRE - Get Free Report) and MindWalk (NASDAQ: HYFT - Get Free Report) are both small-cap healthcare companies, but which is the better stock? We will contrast the two companies based on the strength of t…

FTRE −2.0% todayRead at source ↗
● Defense WorldOct 8, 2026 · 07:07 ET
Ausbil Investment Management Ltd Decreases Stake in Fortrea Holdings Inc. $FTRE

Ausbil Investment Management Ltd trimmed its position in Fortrea Holdings Inc. (NASDAQ: FTRE) by 25.3% during the third quarter, according to the company in its most recent Form 13F filing with the Securities and Exchang…

FTRE −2.0% todayRead at source ↗
● Defense WorldOct 6, 2026 · 10:00 ET
Fortrea (NASDAQ:FTRE) Reaches New 52-Week High – What’s Next?

Fortrea Holdings Inc. (NASDAQ: FTRE - Get Free Report) reached a new 52-week high during trading on Tuesday. The company traded as high as $21.81 and last traded at $22.1050, with a volume of 16613 shares traded. The sto…

FTRE −2.0% todayRead at source ↗
● GlobeNewsWireOct 5, 2026 · 06:30 ETCOMPANY'S OWN WORDS
Fortrea Announces Date for Third Quarter 2026 Financial Results and Conference Call

DURHAM, N.C., Oct. 05, 2026 (GLOBE NEWSWIRE) -- Fortrea (Nasdaq: FTRE) (the “Company”), a leading global contract research organization (“CRO”), today announced that it will release its third quarter 2026 financial resul…

FTRE −2.0% todayRead at source ↗
● Defense WorldOct 1, 2026 · 04:29 ET
Fortrea Holdings Inc. (NASDAQ:FTRE) Stock Rated “Hold” by Sell-Side Brokerages

Fortrea Holdings Inc. (NASDAQ: FTRE - Get Free Report) has received a consensus rating of "Hold" from the twelve brokerages that are covering the company, MarketBeat reports. One analyst has rated the stock with a sell r…

FTRE −2.0% todayRead at source ↗
● Defense WorldSep 30, 2026 · 02:29 ET
Financial Survey: Fortrea (NASDAQ:FTRE) vs. Bullfrog AI (NASDAQ:BFRG)

Fortrea (NASDAQ: FTRE - Get Free Report) and Bullfrog AI (NASDAQ: BFRG - Get Free Report) are both small-cap healthcare companies, but which is the better business? We will compare the two businesses based on the strengt…

FTRE −2.0% todayRead at source ↗
● GlobeNewsWireSep 10, 2026 · 17:08 ETCOMPANY'S OWN WORDS
Fortrea Announces Grant of Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)

DURHAM, N.C., Sept. 10, 2026 (GLOBE NEWSWIRE) -- Fortrea (Nasdaq: FTRE) (the “Company”), a leading global contract research organization (“CRO”), today announced the granting of an inducement award of restricted stock un…

FTRE −2.0% todayRead at source ↗
● GlobeNewsWireSep 10, 2026 · 08:58 ETCOMPANY'S OWN WORDS
Fortrea to Participate in September Investor Conferences

DURHAM, N.C., Sept. 10, 2026 (GLOBE NEWSWIRE) -- Fortrea (Nasdaq: FTRE), a leading global contract research organization (“CRO”), today announced that CEO Anshul Thakral, CFO Jason Knoblauch, and SVP of Investor Relation…

FTRE −2.0% todayRead at source ↗
● BenzingaSep 2, 2026 · 13:31 ET
Fortrea Leverages Early Phase Strengths to Accelerate Market Expansion

Fortrea (NASDAQ:FTRE) signed a definitive agreement to acquire the Early Phase Services division of Worldwide Clinical Trials in an all-cash transaction valued at approximately $45 million.…

FTRE −2.0% todayRead at source ↗
● GlobeNewsWireSep 2, 2026 · 07:00 ETCOMPANY'S OWN WORDS
Fortrea to Acquire Clinical Pharmacology Unit and Bioanalytical Laboratory Operations from Worldwide Clinical Trials

Adds dedicated bioanalytical capabilities and expanded capacity to Fortrea's early clinical development network as Worldwide advances its strategy to scale clinical development, therapeutic leadership and high-growth mar…

FTRE −2.0% todayRead at source ↗
● Seeking AlphaAug 30, 2026 · 11:14 ET
Fortrea Holdings: The Turnaround Is Showing Up In Earnings Before Revenue

Fortrea Holdings Inc. is rated Buy at ~$18.86, driven by an earnings turnaround from aggressive cost reductions, not revenue growth. Adjusted EBITDA rose ~24% in H1 despite a ~3.4% revenue decline, as direct costs and SG…

FTRE −2.0% todayRead at source ↗
GlobeNewsWire · Oct 29, 2026

Kept in their own lane. A press release is the company talking, not reporting.

No upcoming events in the feeds.

Article counts from the last market-wide feed page, across every symbol we track and not just FTRE · day move from the quote feed. Equal counts are listed alphabetically, not ranked. Coverage ≠ importance.

The feed is purely chronological. No materiality ranking, no hidden sentiment score. Timestamps are publisher-reported and arrive with no timezone, so they are read and shown on the US market clock (ET); thumbnails come from each article's image field; day moves from the quote feed. Copies of the same story are collapsed on link or normalized headline, and a company's press release is kept over any syndicated copy of it; "company's own words" means the release title leads with the company's name and the wire names no other organisation first as its issuer; "earnings-tied" is a keyword match while a report date is upcoming. Not investment advice.

Install Tenet on your phone

Tenet home pageMethodology© 2026 Tenet Investing Inc.

Data from Intrinio and Financial Modeling Prep.